By Kate O’Rourke
Atlanta—The use of clinical pathways and oncology medical homes can help rein in the cost of cancer care, but more efforts are needed to limit drug costs. This was the message delivered by several clinicians during a practice panel at the 2016 annual meeting of the Hematology/Oncology Pharmacy Association.
Edward Li, PharmD, MPH, BCOP, an associate professor at the University of New England College of Pharmacy, in Portland, Maine, is part of a team of researchers who